Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

10.71
+0.08000.75%
Post-market: 10.60-0.1100-1.03%19:36 EDT
Volume:93.46K
Turnover:1.00M
Market Cap:375.57M
PE:-89.25
High:10.86
Open:10.66
Low:10.57
Close:10.63
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.89M
Volume Ratio:0.82
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:8.85
PE(LYR):-31.42

Loading ...

Feb 07, 2025

Major Issues Report

Form 8-K - Current report
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Oct 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2024

Major Issues Report

Form 8-K - Current report